An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study)
Clinical trial NCT05037851 · COMPLETED
Trial details
- NCT number
- NCT05037851
- Sponsor
- Pulmocide Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-19
- Primary completion
- 2023-10-19
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.